AA
GILD icon

Argent Advisors’s Gilead Sciences GILD Stock Holding History

Argent Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
11,701
+206
+2% +$27.1K 0.37% 66
2026
Q1 		$1.6M Sell
11,495
-41
-0.4% -$5.74K 0.44% 60
2025
Q4 		$1.42M Sell
11,536
-86
-0.7% -$10.5K 0.4% 63
2025
Q3 		$1.29M Buy
11,622
+798
+7% +$90.7K 0.38% 71
2025
Q2 		$1.2M Buy
10,824
+399
+4% +$42.5K 0.37% 74
2025
Q1 		$1.17M Sell
10,425
-920
-8% -$94.9K 0.39% 69
2024
Q4 		$1.05M Buy
11,345
+142
+1% +$12.8K 0.39% 76
2024
Q3 		$939K Sell
11,203
-83
-0.7% -$6.33K 0.35% 80
2024
Q2 		$774K Buy
11,286
+533
+5% +$35.6K 0.31% 81
2024
Q1 		$788K Sell
10,753
-301
-3% -$23.1K 0.31% 80
2023
Q4 		$895K Sell
11,054
-169
-2% -$13.2K 0.39% 66
2023
Q3 		$841K Buy
11,223
+29
+0.3% +$2.23K 0.38% 66
2023
Q2 		$863K Buy
11,194
+299
+3% +$23.8K 0.4% 68
2023
Q1 		$904K Sell
10,895
-476
-4% -$39.4K 0.43% 61
2022
Q4 		$976K Sell
11,371
-53
-0.5% -$4.2K 0.51% 54
2022
Q3 		$705K Buy
11,424
+391
+4% +$24.7K 0.41% 63
2022
Q2 		$682K Buy
11,033
+1,178
+12% +$72.9K 0.38% 71
2022
Q1 		$580K Buy
+9,855
New +$630K 0.31% 84
2020
Q1 		– Sell
-1,380
Closed -$88K – 266
2019
Q4 		$88K Buy
+1,380
New +$89.9K 0.07% 162

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Argent Advisors's GILD Position: Q2 2026 in Review

Argent Advisors increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $27.1K and bringing the position to 11,701 shares worth $1.48M. The position accounts for 0.37% of the portfolio, ranked #66.

Argent Advisors first reported a position in GILD in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.6M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Argent Advisors held 11,701 shares of Gilead Sciences worth $1.48M as of Q2 2026.
  • Argent Advisors bought 206 Gilead Sciences shares in Q2 2026, an estimated $27.1K.
  • Gilead Sciences made up 0.37% of Argent Advisors's portfolio in Q2 2026, its #66 holding.
  • Argent Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 19 quarters since.
  • Argent Advisors's Gilead Sciences position peaked at $1.6M in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.